Back to User profile » Dr Depei Wu
Papers published by Dr Depei Wu:
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
Hu S, Wu D, Wu J, Zhang Y, Bøgelund M, Pöhlmann J, Pollock RF
Patient Related Outcome Measures 2023, 14:253-267
Published Date: 26 September 2023
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation
Zhang XY, Dai HP, Zhang L, Liu SN, Dai Y, Wu DP, Tang XW
OncoTargets and Therapy 2021, 14:5197-5204
Published Date: 29 October 2021
Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies
Yang R, Zhao Y, Wang X, Sun J, Wu R, Jin C, Jin J, Wu D, Rendo P, Sun F, Rupon J, Huard F, Korth-Bradley JM, Xu L, Luo B, Liu YC
Journal of Blood Medicine 2020, 11:439-448
Published Date: 25 November 2020
Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cells
Yang F, Zhang J, Zhang X, Tian M, Wang J, Kang L, Qiu H, Wu D
OncoTargets and Therapy 2019, 12:2187-2191
Published Date: 25 March 2019